show episodes
 
Artwork

1
Health Care Rounds

John Marchica

Unsubscribe
Unsubscribe
Щомісяця
 
Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in health care business news and policy developments, including interviews with dynamic leaders in health care. John is a veteran health care strategist and is leading ongoing research initiatives on health care delivery systems and value-based care. Tags: ...
  continue reading
 
Hi, my name is Dan Ryland. I've been in the digital industry for 15+ years now. I was working a pretty stable, comfortable job in a digital agency, and I decided to quit to start my own agency. In two short years, I was able to build that into a multi six-figure business, and now I work with the likes of Google, Ford, GSK and more. It doesn't stop there. Over the past 2 years I've been building and launching profitable products across various industries. If you've wanted to start an agency o ...
  continue reading
 
In this series, David Green will be speaking to a range of senior HR leaders who are pushing a data-driven and digital HR agenda. There is an increasing need for HR professionals to become more digitally and numerically literate – to acquire the skills necessary to process, produce and leverage digital information to create business value. You'll hear from people leaders who are driving transformation in their organisations on how HR can prepare for the future and what HR leaders need to do ...
  continue reading
 
AoPcasts is a fascinating series of podcasts bringing cutting edge medical research to new audiences. Produced by the Association of Physicians (AoP) and hosted by science broadcaster Vivienne Parry, the series will explore some of the major themes debated at the annual AoP meeting. The first AoPcast brings together Rino Rappuoli, Chief Scientist of the vaccines division of GSK and Fellow both of the Royal Society and the US National Academy of Sciences, and Ellie Barnes, Professor of Experi ...
  continue reading
 
Artwork

1
Pro Bono Happy Hour

Pro Bono Institute

Unsubscribe
Unsubscribe
Щомісяця
 
Lively conversations about law firm pro bono news, infrastructure, and best practices featuring insightful and entertaining expert guests from PBI’s Law Firm Pro Bono Project member firms, and Law Firm Pro Bono Challenge® signatories, Corporate Pro Bono Challenge® signatories, and from other pro bono and access to justice champions and leaders.
  continue reading
 
Artwork
 
It all starts with people. Each and everyone of us has their own story. We want to tell those stories. In this podcast we're exploring the industry built around understanding people’s motivations. We’re talking to clients, researchers, academics – anyone with a story to tell about market research.
  continue reading
 
A series of one-to-one interviews with leaders of some of Europe’s best known industrial and technology companies. We ask these CEOs and Chairs about their early lives, careers, experiences and leadership lessons. We talk about the challenges of the sectors they are working in, the opportunities they see on the horizon and gauge their views on some of the burning topics of our time.
  continue reading
 
Artwork

1
Digital Conversations

Lifelink Systems

Unsubscribe
Unsubscribe
Щомісяця
 
Conversational technology and patient engagement are two technology trends sweeping through the three trillion dollar healthcare industry. In these short, interactive discussions, industry experts talk about how and where innovation is impacting the customer experience at hospitals, pharmaceutical companies, and the vast array of related services in the industry.
  continue reading
 
Artwork

1
NC tech talks

Northcoders

Unsubscribe
Unsubscribe
Щомісяця
 
NC tech talks is a podcast for people who are starting a career in the tech industry. We bring in expert guests to talk about everything from mental wellbeing as a new technologist to the latest and coolest tools and software.
  continue reading
 
Artwork

1
The CoachIN Podcast

Society 54

Unsubscribe
Unsubscribe
Щомісяця
 
Welcome to the CoachIN podcast presented by Society 54. This podcast will showcase the best revenue generation and strategic marketing tips for attorneys, professional services providers and in-house business development and marketing teams, as well as some insights on personal development and some fun surprises here and there. We will also showcase some of the brightest stars in the industry and learn more about their experiences and roads to success. To learn more about how we can help cre ...
  continue reading
 
Artwork

1
From Campus to Careers

Careers and Placements at Aston University

Unsubscribe
Unsubscribe
Щомісяця
 
Join us as we chat about all things Careers and Placements. We'll be joined by a host of guests to support you every step of the way through your journey as an Aston University student. You can expect to hear about topics such as work experience, CV advice, assessment centres, the placement year and more!
  continue reading
 
Artwork

1
Work Happy by Silicon Reef

Silicon Reef

Unsubscribe
Unsubscribe
Щомісяця
 
Hello and welcome to “Work Happy” – a podcast series focused on using technology to explore better ways of working. I’m your host, Alex Graves, Co-Founder & CEO of Silicon Reef, a leading SharePoint Development Agency and Microsoft Modern Work Solutions Partner which creates people-led solutions that work. I’ve started this podcast to interview those who are leading the future of work within some of the biggest global brands including IKEA, The Cooperative and Virgin Media to name a few.As w ...
  continue reading
 
Loading …
show series
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA has paused Novavax's investigational flu and COVID-flu vaccines due to a serious adverse event of motor neuropathy. This affects their COVID-flu combo and standalone flu vaccines, which were about to enter phase I…
  continue reading
 
We've got plenty for your ears in this episode, listener. We managed to line-up an interview with Sarah Jones MP, Minister of State at both the Department for EnergySecurity and Net Zero, and the Department for Business and Trade. This follows the announcement of the government's Invest 2035 proposal - the UK's modern industrial strategy. Before th…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A study has found that Novo Nordisk's semaglutide may reduce the risk of Alzheimer's disease by 40% to 70%. Roche has entered a potential $1 billion gene therapy deal with Dyno Therapeutics, focusing on neurological diseas…
  continue reading
 
Mattos Filho, Veiga Filho, Marrey Jr. e Quiroga has been a trailblazer in advancing access to justice in Brazil, dedicating its pro bono efforts to some of the most pressing social issues. Their work addresses racial discrimination, women’s rights, LGBTQ+ rights, and refugee protection, leaving a profound and lasting impact on both individuals and …
  continue reading
 
🎙 ABOUT HEALTH CARE ROUNDS Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in health care business news and policy developments. 🎙 ABOUT ERIKA EBBEL ANGLE Dr. …
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche CEO opposes Novo Holdings' acquisition of Catalent, urging for it to be blocked. Roche exceeded Q3 sales expectations, driven by the success of drugs like Ocrevus and Vabysmo. Pfizer's RSV vaccine has been approved …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche has ended its collaboration with UCB on Alzheimer's treatments, marking the third candidate dropped by Roche this year. Meanwhile, activist investor Starboard has set its sights on Kenvue, a division of J&J, follow…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer ResearchIn a groundbreaking study published in Nature Medicine, researchers have identified a new potential target for cancer therapy. This discovery could lead to more effective treatments for a…
  continue reading
 
How is the shift to hybrid and distributed work reshaping the very fabric of your organisation’s networks? And how you can leverage these changes to build more effective teams and drive business success? In this episode of the Digital HR Leaders podcast, David Green is joined by Michael Arena, a pioneer in Organisational Network Analysis (ONA), to …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## New Drug Approval: Title: FDA Approves New Cancer Drug for Treatment of Breast CancerContent: The FDA has approved a new cancer drug for the treatment of breast cancer. This new drug is expected to provide better outc…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Sanofi has signed a $326 million deal with Orano Med for radiopharma, following a similar deal made in September. Sage Therapeutics is laying off 33% of employees to support the launch of its postpartum depression drug. …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##Breaking News: FDA Approves New Cancer DrugIn a groundbreaking development, the FDA has approved a new cancer drug that has shown promising results in clinical trials. The drug is expected to provide hope for patients w…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Danish pharmaceutical company Lundbeck has announced a $2.6 billion deal to acquire Longboard Pharmaceuticals, gaining access to their epilepsy drug currently in late-stage development. The FDA's accelerated approval pathwa…
  continue reading
 
Transforming a global company like Mastercard into an AI-powered, future-focused, skills-driven organisation takes more than just bold ideas—it takes visionary leadership and a deep connection between the people and business strategy. In this episode of the Digital HR Leaders podcast, David Green sits down with Michael Fraccaro, Chief People Office…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has received regulatory approval for its breast cancer drug, inavolisib, for advanced breast cancer, projecting $2.3 billion in peak sales. This drug is seen as a potential competitor to Novartis' pi3k inhibitor piq…
  continue reading
 
Hello listener, ready for a new series? This time, it's Supply Chains themed, and sponsored by our partners, ERIKS. We've got another first rate interview taken from The Manufacturer Studio; Clare Bailey, Supply Chain Master Data Manager at Safran Seats discusses the importance of getting organisations "enabled and upskilled sufficiently" to master…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.GSK has settled Zantac lawsuits for $2.2 billion, resolving 93% of product liability cases regarding allegations that the heartburn drug could cause cancer. Analysts are now shifting focus to the company's vaccines busine…
  continue reading
 
🎙 ABOUT DR. TRUDY HALL Dr. Trudy R. Hall has been the Vice President of Medical Affairs and Chief Medical Officer at TidalHealth since July 2022. She previously served in leadership roles at the University of Maryland's Capital Region Health and other UM health centers, overseeing major facilities, including a 345-bed COVID care site during the pan…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.This week's commercialization news includes updates on Zepbound supply, Enjaymo's new home, and expanding access to HIV drugs. Medicare has tweaked rules for drug price talks, while GSK reports that its RSV vaccine protects…
  continue reading
 
We're back, listener. It's been too long. We bring our Technology Series, sponsored by Sugar CRM, to a close. We've got the thoughts of Martin Crangle, IT Business Relationship Manager at BorgWarner. He spoke to us about data driven decision making, arguing that technology enables us to make sense of data, we've just got to trust it. But we start t…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Sage has decided to discontinue the development of its Alzheimer's drug candidate, dalzanemdor, after disappointing mid-stage readouts. This is the third setback in neurology for the company in six months. Meanwhile, cell a…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Scholar Rock has achieved success in a drug study for spinal muscular atrophy, potentially setting a new standard for treatment. Judo Bio has debuted with $100 million funding to develop RNA drugs for kidney targets. Intell…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.CVS is laying off 2,900 employees as part of a cost-cutting plan and potential business breakup. Humana's Medicare Advantage star ratings have dropped significantly, impacting profits. Healthcare workers face burnout, whi…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The FDA decisions to watch from October 3-5 include the approval of a rival to a fast-selling Pfizer heart drug, a lung cancer medicine, and an addition to Vertex's cystic fibrosis business. Prime is narrowing its gene e…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Bayer has developed a successful audience targeting strategy that drives meaningful engagement, with Crossix audience segments optimizing campaigns and aligning messaging more closely with the patient journey. This precisi…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Artificial intelligence (AI) has the potential to revolutionize clinical trials, particularly in site identification and patient recruitment. AI can address longstanding challenges in clinical research, offering a four-part…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche's investment in startup Regor Therapeutics for a new breast cancer drug, worth $850 million, shows their commitment to innovative research. Prime's focus on gene editing research and partnership with Bristol Myers …
  continue reading
 
What does it take to lead one of Africa's largest banks through a transformative HR journey, affecting 55,000 employees across 28 countries? In this episode of the Digital HR Leaders podcast, Sharon Taylor, Chief People and Culture Officer, and Jaco van Vuuren, Chief Operating Officer for Human Capital at Standard Bank Group, reveal the behind-the-…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Bristol Myers has received approval for a first-of-its-kind schizophrenia drug, Cobenfy, and plans to sell it despite potential insurance barriers for patients. Biogen and UCB are planning a large study for their lupus medi…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Democrats have introduced a bill to make increased Affordable Care Act (ACA) subsidies permanent, arguing that if the enhanced tax credits expire, healthcare costs for millions of Americans will suddenly increase. Meanwhil…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Various developments in the biopharma industry are discussed, including Novo's CEO being pressured to cut prices of obesity and diabetes drugs, the FTC suing major pharmacy benefit managers over insulin prices, Bluebird …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.On September 24, 2024, Ross Segan was appointed to replace Maisel as the head of medical device evaluation and quality at the FDA's Center for Devices and Radiological Health. Route 92 Medical raised $50 million in fundin…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.On September 23, 2024, Lifespan, a healthcare organization, laid off 20% of its executive team as part of a restructuring effort to save $6 million. The FTC sued major pharmacy benefit managers over alleged anticompetitiv…
  continue reading
 
Organisations are finding that the traditional job-based structures are no longer enough to drive innovation and growth. As they face new challenges and opportunities, businesses are beginning to understand that shifting to a skills-based approach is crucial for future success. To explore how moving to a skills-based organisation can open up new po…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Senseonics has received FDA clearance for a one-year continuous glucose monitoring system. The company's commercial partner, Ascensia, is in talks with insulin pump manufacturers to create an automated insulin delivery sy…
  continue reading
 
🎙 ABOUT DR VISHNUKAMAL GOLLA Dr. Vishnukamal Golla is the medical director for value transformation at Evolent, a specialty and primary care management company. In this role, Dr. Golla leads the implementation of innovative value-based care models in specialty care. In helping Evolent manage approximately $1 billion of risk-based oncology and cardi…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Amazon has partnered with Talkspace to expand its digital health benefits program, which also includes Omada Health. Community Health Systems (CHS) subsidiary is acquiring 10 urgent care centers, following in the footste…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Delays in clinical trials can cost up to $8 million per day, making it crucial to understand and address the main factors causing these setbacks. Strategies to keep clinical trials on schedule include identifying common i…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Today's episode covers a range of key topics in the biopharma industry. First, ten-year survival data has revealed the long-term benefits of immunotherapy in melanoma, offering hope for potential cures. Kyverna has announc…
  continue reading
 
With AI transforming how we work, HR needs to be prepared for a complete talent shift. But is the function ready for this new reality? In this episode of the Digital HR Leaders podcast, host David Green sits down with Keith Bigelow, Chief Product Officer at Visier, to explore the critical role HR plays in leading digital transformation—and how AI i…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Target has launched a collection designed by 'fur-fluencers' to attract pet owners, along with reality TV-styled social content and national ads featuring mascot Bullseye. PayPal's new ad campaign stars Will Ferrell and e…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.BridgeBio has trimmed its gene therapy budget after data on an adrenal gland medicine fell short of expectations. Gene therapy startup Vironexis has received approval for a first-of-its-kind trial testing a cancer drug de…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. This week's commercialization news includes Dupixent's success in a chronic hives study, Lilly's development of a weekly insulin shot, and BioMarin's plans for growth. The House backs a bill restricting China's role in US …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.EPRO, or electronic patient-reported outcomes, is increasingly used in clinical trials to improve data accuracy, patient compliance, and reduce administrative burdens. Swing Therapeutics achieved 98% patient compliance in t…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Candid, a startup, is investing $370 million to prove the worth of bispecifics in autoimmune diseases. Summit's lung cancer drug has shown significant benefits over Keytruda, a popular immunotherapy drug. Relay's breast can…
  continue reading
 
Loading …

Короткий довідник